Division Directors

Cardiology

Dr. Paul Dorian

Dr. Dorian

 

Dr. Paul Dorian is the Department Division Director, Division of Cardiology, and a staff cardiac electrophysiologist at St. Michael's Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology and Toxicology at the University of Toronto, and a staff scientist at the Li Ka Shing Knowledge Institute. 

Dr. Dorian received his medical degree from McGill University in Montreal in 1976. He continued training in internal medicine and cardiology at the University of Toronto, and received certification by the Royal College of Physicians and Surgeons of Canada in internal medicine in 1983 and certification in cardiology in 1984. He completed training in clinical pharmacology at the University of Toronto in 1982, and received an MSc in pharmacology from the University of Toronto in 1982. From 1983 to 1985, he completed a fellowship in cardiac electrophysiology at Stanford University Medical Centre in California.

His research interests include basic science research in advanced cardiac life support and atrial fibrillation, the clinical pharmacology of antiarrhythmic drugs, and clinical research on implanted devices, antiarrhythmic drugs, and quality of life in patients with arrhythmias. 

He is the immediate past-president of the Canadian Heart Rhythm Society, chair of the Cardiac Arrest Committee, St. Michael’s Hospital, co-PI on the NIH funded Resuscitation Outcomes Consortium, and serves on the steering committee of multiple multicentre clinical trials in arrhythmia care. He is the chair of the Canadian Cardiovascular Society Quality Committee.

He has published over 370 peer reviewed papers and is associate editor of the textbook Electrophysiological Disorders of the Heart.

Clinical Immunology and Allergy

Dr. Gordon Sussman

Dr. Sussman

Dr. Gordon Sussman began his career at a time when immunology was just beginning to increase in importance interfacing with all specialties of medicine. He  witnessed first-hand the exponential increase in knowledge of immunology in the pathophysiology of diseases.The past 30 years have been a truly exciting time for immunology starting as a dormant program with metamorphosis to a vibrant new specialty.

Dr. Sussman had the privilege of identifying one of the earliest reports of natural rubber latex allergy. In the 1990s latex allergy reached epidemic numbers. He identified, characterized and cloned several allergens. Working with government, industry, and healthcare facilities we eliminated at risk exposures with almost complete disappearance of this within 20 years.

He has also witnessed the quadrupling in the incidence of some allergies. We have seen the emergence of new strategies to prevent this from continuing. Our research programs have continued to expand, contribute, and have international recognition. We have seen and studied many new treatments including immunotherapy to treat and prevent anaphylactic allergy to stinging insects and peanut. 

New biologic treatments have allowed more precise interventions to treat inflammatory and allergic diseases. This has resulted in seminal changes of the way we think about these diseases.

Perhaps the most gratifying has been the expansion of our training program with many new individuals choosing allergy and clinical immunology as a career choice.

Clinical Pharmacology and Toxicology

Dr. David Juurlink

Dr. Juurlink

Dr. David Juurlink is an internist and head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto. He is also a medical toxicologist at the Ontario Poison Centre at the Hospital for Sick Children and a scientist at the Institute for Clinical Evaluative Sciences.

He received degrees in pharmacy and medicine from Dalhousie University in Halifax, Nova Scotia, and completed postgraduate training in internal medicine followed by residency in clinical pharmacology, a fellowship in medical toxicology, and a PhD in clinical epidemiology, all at the University of Toronto. He received certification by the American Board of Internal Medicine, the American Board of Clinical Pharmacology, and the American Board of Emergency Medicine (Medical Toxicology.)

He is presently the principal consultant and Sunnybrook site director for the program in clinical pharmacology and vice-chair of the Examination Board of the Royal College of Physicians and Surgeons program in clinical pharmacology and toxicology. In addition to his clinical, teaching and administrative activities, he maintains an active research program in the field of drug safety. His areas of particular interest include adverse drug events, the clinical consequences of drug-drug interactions in real-world practice, and the epidemiology of suicide and para-suicide.

Critical Care

Dr. Laurent Brochard

Brochard, Laurent 2017-06

Dr. Laurent Brochard is the Interdepartmental Division Director, Critical Care, at the University of Toronto. He is a full professor and clinician-scientist in the Division of Critical Care at St. Michael’s Hospital. He was previously working in Geneva as head of the Intensive Care Unit of the Geneva University Hospital, in Switzerland for three years. Most of his career took place at Henri Mondor Hospital, Assistance Publique – Hôpitaux de Paris, and at Paris EST University, France. He has a strong involvement in research, and especially clinical research about mechanical ventilation. He has been editor-in-chief of the journal, Intensive Care Medicine, from 2001 to 2007 and is currently serving as deputy editor for the American Journal of Respiratory and Critical Care Medicine. He is leading a European Research Network dedicated to clinical studies in mechanical ventilation called REVA.

Dermatology

Dr. Neil Shear

Dr. Shear

Dr. Neil Shear graduated with a degree in engineering science from the University of Toronto in 1973 and earned his medical degree at McMaster University, Hamilton, in 1976. Dr. Shear completed training in both internal medicine and dermatology recognized by the Royal College of Physicians and Surgeons of Canada and the American Board. He also completed a fellowship in clinical pharmacology, supported by the Medical Research Council of Canada, at the Hospital for Sick Children in Toronto. Dr. Shear joined the staff of Sunnybrook Health Sciences Centre in Toronto in 1984 and is now the head of Dermatology at Sunnybrook  and Women's College Hospital and the director of the University of Toronto Drug Safety Research Group. Dr. Shear founded the Drug Safety Clinic at Sunnybrook in 1985 and was the founding chair of the Canadian Adverse Drug Reaction Advisory Committee (CADRAC) of Health Canada.

Dr. Shear has conducted numerous clinical trials in dermatology, from first in human early pharmacology studies to large randomized trials of novel therapeutics, and he is Vice-President of Research and Development (Dermatology) at Ventana Clinical Research. His research has been funded by numerous peer reviewed agencies and the pharmaceutical industry. Dr. Shear’s main interest is in idiosyncratic drug reactions that involve the skin. He has published 200 peer reviewed papers and numerous chapters and abstracts. His clinical interests are diverse, from rosacea and camouflage makeup to autoimmune blistering diseases. Dr. Shear is a past president of the Canadian Society for Clinical Pharmacology and a recipient of the society’s Distinguished Service Award. He is chair of the Canadian Association of Professors of Dermatology, president of the Canadian Dermatology Foundation, and a member of the prestigious American Dermatology Association. He was the founding editor of the Canadian Journal of Clinical Pharmacology, is the associate editor of the Journal of Cutaneous Medicine and Surgery, and deputy editor of Journal Watch Dermatology.

 

Emergency Medicine

Dr. Anil Chopra

Anil Chopra

Dr. Anil Chopra completed his fellowship in emergency medicine at the University of Toronto and has been active staff at the University Health Network (UHN) since 1994. He has been the chief of the Emergency Department at the UHN for the last ten years and is associate professor in the Department of Medicine at the University of Toronto. Dr. Chopra has also been an active member of the Department of Medicine’s Continuing Faculty Appointment Review Committee.

Dr. Chopra is a very well regarded administrator and clinician who has a passion for quality improvement and innovation. He has received several teaching awards including the W.A. Anderson Teaching Award for Undergraduate Teaching and the Anna Jarvis Award for Postgraduate Teaching Excellence. His clinical and research interests are in the area of arterial and venous thromboembolism and he is an executive member of Thrombosis Canada. Dr. Chopra has numerous publications focused on the assessment, prevention and management of thromboembolism.

Endocrinology and Metabolism

Dr. Gary Lewis

Dr. Lewis

Dr. Gary Lewis completed his medical training in 1982 at the University of Witwatersrand in South Africa, followed by specialty training in internal medicine and then endocrinology at the University of Chicago. He joined the staff of the Toronto General Hospital in 1990, was appointed head of the Division of Endocrinology at University Health Network and Mount Sinai Hospitals in 2001, Department Division Director, Division of Endocrinology and Metabolism, Department of Medicine at the University of Toronto (U of T) in 2008 and director of the Banting and Best Diabetes Centre, U of T, in 2011. Dr. Lewis is the principal applicant on a recently awarded $31million Canadian Network grant in diabetes and its related complications.  He is a full professor in the Departments of Medicine and Physiology, University of Toronto, and he holds the Sun Life Financial Chair in Diabetes and the Drucker Family Chair in Diabetes Research.

Dr. Lewis has made a number of seminal discoveries elucidating the mechanism of blood fat abnormalities in diabetes and prediabetic states. The specific areas in which his research has had a major impact are the study of postprandial lipoprotein metabolism, the mechanism of HDL lowering, the mechanism of triglyceride rich lipoprotein overproduction by liver and intestine and the mechanism of free fatty acid impairment of pancreatic insulin secretion, the latter potentially contributing to pancreatic failure and the development of type 2 diabetes. He is recognized internationally as a foremost expert in the field of lipoprotein metabolism in insulin resistance and diabetes.  

Dr. Lewis has been awarded and honoured by several organizations. To mention a few, he is the recipient of the 2016 Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology Scientific Excellence Award, the 2013 Canadian Society for Clinical Investigation (CSCI) Distinguished Scientist Award and Lecture, a Canada Research Chair in Diabetes, the Canadian Diabetes Association Young Scientist Award, and has been elected to the American Society for Clinical Investigation and the Canadian Academy for Health Sciences. He has been invited to present his research findings at numerous universities around the world and at prestigious international meetings.

Gastroenterology

Dr. Johane Allard

Dr. Allard

Dr. Johane P. Allard is Professor of Medicine at the University of Toronto and is crossed-appointed to the Department of Nutritional Sciences and Institute of Medical Sciences. She trained in gastroenterology at McGill University before completing a research fellowship funded by the National Institute of Nutrition at the University of Toronto.

Dr. Allard is a clinician-investigator, with a research focus in nutrition and gastrointestinal disorders. She is currently conducting several studies funded by peer review agencies in patients requiring nutrition support, people with non-alcoholic steatohepatitis (NASH) and patients with morbid obesity undergoing bariatric surgery. She is also conducting research on malnutrition in Canadian hospitals and has developed a research program on the intestinal microbiome related to the metabolic-syndrome. Her publications are primarily in the area of micronutrients, oxidative stress, nutrition support and NASH.

Dr. Allard is also the Department Division Director, Division of Gastroenterology, at the University of Toronto and the director of the Nutrition Support Program at the University Health Network (UHN). She works with a multidisciplinary nutrition support team and is the chair of the Nutrition Review Committee. She is the past-chair of the Royal College of Physician and Surgeons Examining Board in Gastroenterology and co-founder of the Canadian Nutrition Society.

General Internal Medicine

Dr. Moira Kapral

Moira Kapral

Dr. Moira Kapral is a professor in the Department of Medicine and holds the Mr. Mak Pak Chiu and Mrs. Mak-Soo Lai Hing Chair in General Internal Medicine. She is a staff physician in the Division of General Internal Medicine at the University Health Network (UHN)/Mount Sinai Hospital. She served as internal medicine clerkship coordinator (1998-2004) and site director for the Internal Medicine Postgraduate Program (2005-2008) at the Toronto General Hospital. She has received prestigious University of Toronto awards including the Mary Hollington Award for Teaching, the Aikens Award for Teaching and the Wightman-Berris Academy Award for Teaching. She also received numerous UHN awards including the Award for Excellence in Clinical Teaching, the J.G. Scott Teacher of the Year Award, the W.H. Anderson Award for Individual Teaching Excellence, and the Young Attending Teacher Award.
 
Her research focus is on stroke health services research and she is a senior scientist at the Institute for Clinical Evaluative Sciences and the Toronto General Research Institute. She has held almost $14 million in grant funding as well as national career awards from the Canadian Institutes for Health Research (2006-2011) and the Heart and Stroke Foundation of Canada (2011-2016). Dr. Kapral was the co-principal investigator of the Registry of the Canadian Stroke Network/Ontario Stroke Registry.

Geriatric Medicine

Dr. Sharon Straus

Dr. Straus

Dr. Sharon Straus is a full professor in the Department of Medicine at the University of Toronto. She holds a Tier 1 Canada Research Chair in Knowledge Translation and Quality of Care and more than $30 million in peer reviewed research grants as a principle investigator. She also holds the Mary Trimmer Chair in Geriatric Medicine.

She has >300 publications, and has supervised >25 graduate students from different disciplines including clinical epidemiology, health informatics and human factors engineering. She is co-PI of KT Canada, a CIHR and CFI funded national, Clinical Research Initiative, PI of KT Canada’s CIHR-funded Strategic Training Initiative in Health Research and PI of a network meta-analysis team grant for the Drug Safety and Effectiveness Network. She is division director of Geriatric Medicine at the University of Toronto and director of the KT Program at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital.

She has authored three books: Evidence-based medicine: How to practice and teach it is in its fourth edition and has been published in nine languages; Knowledge Translation in Health Care is now in its second edition; and the first edition of Mentorship in Academic Medicine.

Hematology

Dr. Isaac Odame

Dr. Odame

Dr. Isaac Odame is a staff physician in the Division of Hematology/Oncology and the Centre for Global Child Health at the Hospital for Sick Children, Toronto, Canada. He is a full professor and director of the combined Division of Adult and Pediatric Hematology in the Departments of Medicine and Pediatrics, Faculty of Medicine, University of Toronto. He holds the Alexandra Yeo Chair in Hematology at the University of Toronto.

The focus of Dr. Odame’s academic work and clinical care are patients with sickle cell disease, and thalassemias and other hematological disorders. Currently, Dr. Odame is the director of the Global Sickle Cell Disease Network based at the Hospital for Sick Children and Centre for Global Child Health that is committed to building enduring collaborations between clinicians and scientists worldwide. Under his leadership sickle cell disease clinicians and scientists across Africa, the Middle East, India, Europe and North and South America are working more collaboratively in research initiatives aimed at delivering interventions that are evidence-based, cost-effective and sustainable over the long-term, particularly in low-income countries with the highest disease burden.

Dr. Odame was previously an associate professor at McMaster University where he was also the director of the residency program in Pediatric Hematology/Oncology. He is a medical graduate of the University of Ghana and undertook his specialty training in pediatrics and hematology/hematopathology in the UK.

Infectious Diseases

Dr. Rupert Kaul

Dr. Kaul

Dr. Rupert Kaul is a full professor and Division Director, Division of Infectious Diseases, University of Toronto, and division head, Infectious Diseases, at the University Health Network/Mount Sinai Hospital. Dr. Kaul became interested in HIV research soon after completing his infectious disease clinical training. For his initial research exposure, Dr. Kaul travelled to Nairobi where he studied a population of HIV resistant sex workers in Nairobi under the supervision of Dr. Frank Plummer from Winnipeg, and the linkage between sexually transmitted disease prevention and HIV in a separate cohort with Dr. Stephen Moses. Today, Dr. Kaul's research investigates the immune correlates of HIV susceptibility and transmission in cohorts of people from Canada, Uganda and Kenya.

Medical Oncology

Dr. Kathy Pritchard

Kathy_Pritchard

Dr. Kathy Pritchard is the Department Division Director, Division of Medical Oncology, at the University of Toronto (U of T), professor in the Departments of Medicine and the Institute for Health Policy Management and Evaluation, and a senior scientist at the Sunnybrook Research Institute (SRI). She graduated from Queen’s University [BA (Science) 1968 and MD (1971)], and trained in internal medicine and medical oncology as well as completing two years of fellowship in clinical trials in melanoma and breast cancer, all at U of T.

Dr. Pritchard was the first to show that tamoxifen is effective and equivalent to ovarian ablation in premenopausal women with metastatic disease and one of the first to describe its role in postmenopausal adjuvant therapy. She co-designed, co-conducted and co-published the practice changing NCIC CTG MA.17 study, the first trial that showed that an aromatase inhibitor or any endocrine therapy could further reduce recurrence rates and improve overall survival in post-menopausal women who had completed five years of adjuvant tamoxifen.

Dr. Pritchard has been chair/co-chair of the Early Breast Cancer Collaborative Group (EBCTCG) since 2000 and has been responsible, together with the Oxford Overview Secretariat led by Sir Richard Peto, for the publication of a series of articles examining the role of endocrine therapy (tamoxifen, ovarian ablation, aromatase inhibitors), bisphosphonates, radiation therapy and various types of chemotherapy in the treatment of early breast cancer following primary surgery. Dr. Pritchard was named as one of the top 1% Highly Cited Researchers worldwide (2014 and 2015) by Thomson Reuters.

Nephrology

Dr. Philip Marsden

Dr. MarsdenPhoto courtesy of St. Michael's Hospital

Dr. Philip A. Marsden is a clinician-scientist and nephrologist at the University of Toronto and St. Michael’s Hospital. He is a full professor in the Department of Medicine. His research is aimed at understanding the contribution of important endothelial genes to disease processes and novel aspects of how these endothelial genes are regulated. His 130 peer reviewed papers have over 9000 literature citations in high-impact journals and address the molecular basis for serious diseases of the cardiovascular and renal systems. For instance, Dr. Marsden’s laboratory and collaborators described in 1992 the cloning, characterization and functional expression of the NO synthase that produces nitric oxide within endothelial cells. His work often targets cutting edge processes or molecular pathways regulating gene expression. He has recently focused on identifying epigenetic or chromatin-based pathways that are relevant to how the endothelial phenotype is regulated in health and disease.

Dr. Marsden has received several awards for his research from the Heart and Stroke Foundation (HSF), the Kidney Foundation of Canada, the Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology and the Department of Medicine at the University of Toronto. He is a member of prestigious societies, such as the American Society of Clinical Investigation (ASCI)(1999), the American Association of Physicians (AAP)(2013), the Canadian Academy of Health Sciences (2013), and the Royal Society of Canada (2014). He has served on a number of editorial boards and research advisory committees. He served as the only Canadian representative on the editorial board of the New England Journal of Medicine (2002-2014). He co-edits the major textbook in nephrology. He is the Lisa Hofmann Chair in Translational Medicine at the University of Toronto and St. Michael’s Hospital.

Dr. Marsden has held a number of leadership roles. He presently serves as the University of Toronto Department Division Director, Division of Nephrology.He has contributed his research expertise to three Canadian Institutes of Health Research (CIHR) operating grant panels as well as the Kidney Foundation of Canada. He is currently funded by CIHR and NIH. Over his career he has always championed group scientific interactions in order to enhance science at the interface of clinical and basic concepts, and the value of scientific collaborations.

 

Neurology

Dr. Anthony Lang

Dr. Anthony Lang

Dr. Anthony Lang’s research has included clinical studies of poorly recognized neurological disorders, clinical trials of new therapeutic modalities and collaborative basic and clinical studies involving molecular biology, neurophysiology, neuropsychology and imaging. He has published over 600 peer reviewed papers, many in important medical journals including the New England Journal of Medicine, Nature Medicine, the Lancet and Lancet Neurology, the Annals of Neurology, Brain, and Movement Disorders. In 2011 he was listed as the most highly cited investigator in the field of Parkinson’s disease for the decade 2001-2009, and in 2013 he was listed as one of the most influential (top-400) living core biomedical researchers based on publications between 1996 and 2011. 

Dr. Lang was one of the founding members and initial executive committee members of the Parkinson Study Group (PSG). He has served on multiple steering committees for important clinical research trials including the first large scale study of neuroprotective therapies in Parkinson’s disease (the DATATOP trial) carried out by the PSG, and funded by NIH.

He has been involved in developing a number of rating scales for movement disorders including the most widely applied scale for cervical dystonia (the Toronto Western Spasmodic Torticollis Rating scale; affectionately known throughout the world as the TWSTRS), and a disability scale for Levodopa-induced dyskinesias (the Lang-Fahn rating scale) as well as the original Unified Parkinson Disease Rating Scale (UPDRS) and the recent revision by the Movement Disorder Society (MDS) the MDS-UPDRS.

Dr. Lang has served in numerous leadership roles in the international Movement Disorder Society (MDS) including the MDS International Executive Committee and as treasurer from 1988-1992 and secretary from 1996-1998. He served as the MDS president from January 2007- June 2009. He was co-editor-in-chief of the international journal Movement Disorders between 1996 and 2003 inclusive.  

Dr. Lang has won a number of research awards including the American Academy of Neurology Movement Disorders Research Award in 2004 and the University of Toronto Department of Medicine Research Award in 2008. He has given many named lectures including the MDS Stanley Fahn lectureship and the World Federation of Neurology’s Melvin Yahr lectureship, both in 2011, and the Association of British Neurologists’ Gordon Holmes Lecture in 2015. In 2010, he was appointed as an officer of the Order of Canada and in 2011 he was elected a fellow of both the Canadian Academy of Health Sciences and the Royal Society of Canada.

Occupational Medicine

Dr. Linn Holness

Dr. Linn Holness

Dr. Linn Holness graduated from the Faculty of Medicine, University of Toronto, in 1977 and has a MHSc from the University of Toronto. She is certified in Occupational Medicine by the Royal College of Physicians and Surgeons of Canada and is an Honorary Fellow of the Faculty of Occupational Medicine of the Royal College of Physicians of London, UK.

Dr. Holness is a full professor in the Dalla Lana School of Public Health and Department of Medicine at the University of Toronto and Department Division Director, Occupational Medicine, in the Department of Medicine. She is the chief of the Department of Occupational and Environmental Health at St Michael’s Hospital and holds an appointment in the Centre for Urban Health Solutions. She has served in leadership positions in professional organizations in occupational medicine and contact dermatitis.  

Dr. Holness is the director of the Centre for Research Expertise in Occupational Disease, which focuses on the prevention of common non-malignant occupational diseases. The centre has an applied research focus and works closely with provincial occupational health and safety system partners. Her research interests in occupational health are broad, covering a variety of topics including occupational disease and its prevention, recognition and reporting of occupational disease, occupational health services and occupational health and safety in the context of specific populations such as vulnerable workers. Her research focus has been on prevention, healthcare utilization, diagnosis, return to work and outcomes related to occupational skin disease. 

Physical Medicine and Rehabilitation

Dr. Larry Robinson

Dr. Robinson

Originally from Boston, Dr. Larry Robinson completed his physical medicine and rehabilitation (PM&R) residency at Northwestern University/Rehabilitation Institute of Chicago in 1985, and after a few years on the faculty at the University of Pittsburgh moved to the University of Washington (UW) in Seattle in 1989. Over 25 years at UW, he took on a variety of administrative roles: service chief at Harborview (a Seattle hospital not unlike Sunnybrook Health Sciences Centre); department chair; and vice dean for Graduate Medical Education (known as PGME in Canada) and for Clinical Affairs. He moved to the University of Toronto in 2014.

Dr. Robinson has been involved in a number of national activities in PM&R in the US. He serves as a director for the American Board of PM&R and is a member of the exam committee for the neuromuscular board certification exam. He has also served as chair of the American Board of Electrodiagnostic Medicine (ABEM) and has been active in the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM).  He has served as a board member of the Association of Academic Physiatrists (AAP) and the AAP liaison to the AAMC. Dr. Robinson serves as an editorial board member for the American Journal of PM&R. 

Dr. Robinson has more than 100 journal articles in the peer reviewed medical literature. These are primarily related to electrodiagnosis and electrophysiology. They cover diagnosis and prognosis of entrapment neuropathies, traumatic neuropathy, hypoxic ischemic coma, and statistical approaches to interpretation of multiple data points.

Respirology

Dr. Douglas Bradley

Dr. Bradley

Dr. Douglas Bradley is Professor of Medicine and Department Division Director, Respirology, at the University of Toronto, the Cardiopulmonary Sleep Disorders and Research Centre at the Toronto General Hospital/University Health Network, and the Sleep Research Laboratory at the Toronto Rehabilitation Institute. He also holds the Cliff Nordal Chair in Sleep Apnea and Rehabilitation Research at the Toronto Rehabilitation Institute and the Godfrey S. Pettit Chair in Respiratory Medicine.

Dr. Bradley completed his MD degree at the University of Alberta in Edmonton in 1978. Subsequently, he completed specialty training at the University of Toronto in internal medicine in 1982 and respirology in 1985. Following completion of clinical training he went on to complete three years of research training in sleep apnea and respiratory muscle physiology at the University of Toronto and McGill University, respectively. He has been on staff at the Toronto General Hospital and at the University of Toronto since 1985.

His clinical and research work focuses on the relationship between sleep apnea and cardiovascular diseases, with a particular focus on the pathophysiology and treatment of sleep apnea in patients with heart failure. He holds several peer reviewed grants from the Canadian Institutes of Health Research (CIHR), the Ontario Centres of Excellence and the Heart and Stroke Foundation of Ontario. He has published over 200 papers and book chapters on sleep apnea and related topics.

Rheumatology

Dr. Heather McDonald-Blumer

Heather McDonald-Blumer

 

Dr. Heather McDonald-Blumer completed her internal medicine and rheumatology training at the University of Toronto. Following initial community rheumatology practice she transitioned to a full-time academic appointment in the Department of Medicine in 2004.

For the past 12 years, Dr. McDonald-Blumer has been a member of the Division of Rheumatology at Mount Sinai Hospital/University Health Network. Her clinical interests include osteoporosis and inflammatory joint disease. She is the associate director of the Osteoporosis Program at University Health Network, and is a member of the Scientific Advisory Committee and chair of the Guidelines Committee for Osteoporosis Canada.

She has been an active member of the rheumatology community locally and nationally, having served as the University of Toronto program director for rheumatology as well as chair of the Specialty Committee in Rheumatology and chair of the Examination Board for rheumatology for the Royal College of Physicians and Surgeons of Canada. Her work has advanced rheumatology training across the country through curricular innovations. In recognition of these contributions, Dr. McDonald-Blumer was awarded the Royal College Program Director of the Year Award as well as the inaugural Canadian Rheumatology Association Teacher/Educator of the Year Award.

From 2009-2016, Dr. McDonald-Blumer was the program director for the Internal Medicine Residency Training Program in the Department of Medicine. She has been awarded the William Goldie Travel Prize and Award for medical education and the Teacher of the Year Award to recognize the impact of her work and leadership within the internal medicine program. Complementing her local role, she was the vice-chair of the Canadian Association of Internal Medicine Program Directors during 2015-2016, a group working to share best educational practices in internal medicine training and work with the Royal College to define the internal medicine standards for the incoming competency-based curriculum.

 

Back to Top